These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3925586)

  • 1. [UDP-glucuronosyltransferases and glucuronoconjugation].
    Siest G; Boutin JA; Magdalou J; Batt AM; Antoine B; Fournel S; Thomassin J
    Therapie; 1985; 40(3):139-53. PubMed ID: 3925586
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of monoxygenases in the metabolism of drugs in the human fetus and newborn infant].
    Cresteil T; Leroux JP
    Arch Fr Pediatr; 1982; 39(7):463-70. PubMed ID: 6816186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recent data on the metabolism of drugs by UDP-glucuronosyltransferases and sulfotransferases (author's transl)].
    Batt AM; Magdalou J; Martin N; Lepage C; Kiffel L; Siest G
    Ann Biol Clin (Paris); 1980; 38(1):35-47. PubMed ID: 6769373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloramphenicol glucuronyl transferase: assay, ontogeny and inducibility.
    Young WS; Lietman PS
    J Pharmacol Exp Ther; 1978 Jan; 204(1):203-11. PubMed ID: 412948
    [No Abstract]   [Full Text] [Related]  

  • 5. Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family.
    Ebner T; Burchell B
    Drug Metab Dispos; 1993; 21(1):50-5. PubMed ID: 8095226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure characterization, and enzyme screening of clenbuterol glucuronides.
    Alonen A; Gartman M; Aitio O; Finel M; Yli-Kauhaluoma J; Kostiainen R
    Eur J Pharm Sci; 2009 Jul; 37(5):581-7. PubMed ID: 19447177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in UDP-glucuronosyltransferase activities in mice and rats.
    Shiratani H; Katoh M; Nakajima M; Yokoi T
    Drug Metab Dispos; 2008 Sep; 36(9):1745-52. PubMed ID: 18505787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased uridine diphosphate-glucuronyltransferase activity in preneoplastic liver nodules and Morris hepatomas.
    Bock KW; Lilienblum W; Pfeil H; Eriksson LC
    Cancer Res; 1982 Sep; 42(9):3747-52. PubMed ID: 6179609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UDP-glucuronosyltransferases and clinical drug-drug interactions.
    Kiang TK; Ensom MH; Chang TK
    Pharmacol Ther; 2005 Apr; 106(1):97-132. PubMed ID: 15781124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of human hepatic UDP-glucuronosyltransferase activity.
    Little JM; Lester R; Kuipers F; Vonk R; Mackenzie PI; Drake RR; Frame L; Radominska-Pandya A
    Acta Biochim Pol; 1999; 46(2):351-63. PubMed ID: 10547036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human UDP-glucuronosyltransferases: structural aspects and drug glucuronidation.
    Ouzzine M; Barré L; Netter P; Magdalou J; Fournel-Gigleux S
    Drug Metab Rev; 2003 Nov; 35(4):287-303. PubMed ID: 14705862
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of photoaffinity labeling with [11,12-3H]all-trans-retinoic acid to characterization of rat liver microsomal UDP-glucuronosyltransferase(s) with activity toward retinoic acid.
    Little JM; Radominska A
    Biochem Biophys Res Commun; 1997 Jan; 230(3):497-500. PubMed ID: 9015348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uridine diphosphate glucuronyltransferase. Structure and catalytic properties].
    Golovenko NIa
    Usp Sovrem Biol; 1980; 89(3):360-76. PubMed ID: 6774504
    [No Abstract]   [Full Text] [Related]  

  • 14. A recombinant phenobarbital-inducible rat liver UDP-glucuronosyltransferase (UDP-glucuronosyltransferase 2B1) stably expressed in V79 cells catalyzes the glucuronidation of morphine, phenols, and carboxylic acids.
    Pritchard M; Fournel-Gigleux S; Siest G; Mackenzie P; Magdalou J
    Mol Pharmacol; 1994 Jan; 45(1):42-50. PubMed ID: 8302279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions.
    Bock KW; Köhle C
    Biochem Pharmacol; 2009 May; 77(9):1458-65. PubMed ID: 19150343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucuronidation of haloperidol by rat liver microsomes: involvement of family 2 UDP-glucuronosyltransferases.
    Narayanan R; LeDuc B; Williams DA
    Life Sci; 2004 Apr; 74(20):2527-39. PubMed ID: 15010263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios.
    Williams JA; Hyland R; Jones BC; Smith DA; Hurst S; Goosen TC; Peterkin V; Koup JR; Ball SE
    Drug Metab Dispos; 2004 Nov; 32(11):1201-8. PubMed ID: 15304429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucuronidation of all-trans-retinoic acid and 5,6-epoxy-all-trans-retinoic acid. Activation of rat liver microsomal UDP-glucuronosyltransferase activity by alamethicin.
    Little JM; Lehman PA; Nowell S; Samokyszyn V; Radominska A
    Drug Metab Dispos; 1997 Jan; 25(1):5-11. PubMed ID: 9010623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP 2C19 and UDP-glucuronosyltransferases not only for drugs but also for endobiotics.
    Siest G; Fournel-Gigleux S; Magdalou J
    Drug Metabol Drug Interact; 2014; 29(4):207-9. PubMed ID: 25367614
    [No Abstract]   [Full Text] [Related]  

  • 20. Rapid prediction of chemical metabolism by human UDP-glucuronosyltransferase isoforms using quantum chemical descriptors derived with the electronegativity equalization method.
    Sorich MJ; McKinnon RA; Miners JO; Winkler DA; Smith PA
    J Med Chem; 2004 Oct; 47(21):5311-7. PubMed ID: 15456275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.